NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Aprogen Pharmaceuticals Inc (KO: 003060)

 
003060 Technical Analysis
4
As on 14th Jan 2025 003060 STOCK Price closed @ 649.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 446.25 & Strong Buy for SHORT-TERM with Stoploss of 353.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

003060STOCK Price

Open 666.00 Change Price %
High 666.00 1 Day -4.00 -0.61
Low 647.00 1 Week -2.00 -0.31
Close 649.00 1 Month -71.00 -9.86
Volume 427782 1 Year 274.00 73.07
52 Week High 1555.00 | 52 Week Low 123.90
 
KO Korea Most Active Stocks
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
006340 3890.00 -2.51%
006340 3890.00 -2.51%
001380 3635.00 8.83%
001380 3635.00 8.83%
005930 53900.00 -0.37%
014160 1360.00 2.18%
 
KO Korea Top Gainers Stocks
168490 159.00 29.27%
168490 159.00 29.27%
010100 3730.00 15.48%
010100 3730.00 15.48%
001527 9900.00 15.38%
001527 9900.00 15.38%
009730 1363.00 14.63%
008730 29800.00 13.96%
008730 29800.00 13.96%
019490 3375.00 11.94%
 
KO Korea Top Losers Stocks
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
001745 3600.00 -46.27%
001745 3600.00 -46.27%
016385 10450.00 -37.05%
016385 10450.00 -37.05%
012170 278.00 -29.80%
004565 4910.00 -24.69%
 
 
003060
Daily Charts
003060
Intraday Charts
Whats New @
Bazaartrend
003060
Free Analysis
 
003060 Important Levels Intraday
RESISTANCE685.61
RESISTANCE673.87
RESISTANCE666.61
RESISTANCE659.36
SUPPORT638.65
SUPPORT631.39
SUPPORT624.13
SUPPORT612.39
 
003060 Forecast January 2025
4th UP Forecast1238.32
3rd UP Forecast1049.32
2nd UP Forecast932.5
1st UP Forecast815.67
1st DOWN Forecast482.33
2nd DOWN Forecast365.5
3rd DOWN Forecast248.68
4th DOWN Forecast59.68
 
003060 Weekly Forecast
4th UP Forecast687.54
3rd UP Forecast675.18
2nd UP Forecast667.54
1st UP Forecast659.90
1st DOWN Forecast638.10
2nd DOWN Forecast630.46
3rd DOWN Forecast622.82
4th DOWN Forecast610.46
 
003060 Forecast2025
4th UP Forecast3843.33
3rd UP Forecast2818.89
2nd UP Forecast2185.66
1st UP Forecast1552.43
1st DOWN Forecast-254.43
2nd DOWN Forecast-887.66
3rd DOWN Forecast-1520.89
4th DOWN Forecast-2545.33
 
 
003060 Other Details
Segment EQ
Market Capital 406541369344.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
003060 Address
003060
 
003060 Latest News
 
Your Comments and Response on Aprogen Pharmaceuticals Inc
 
003060 Business Profile
Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea. Address: Halla Sigma Valley 442-2, Seongnam-si, South Korea
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service